GTCR

Investor type

PE

Founded

1980

AUM

$40 000 M

Location

Chicago, Illinois, United States

Investment Ticket

$50-100 m

Investment Stage

Series B Series A Late Stage (Series C+)

Region of investment

North America Europe
Investor profile last updated: 16 August, 2026

Profile

GTCR is a private equity firm based in Chicago, Illinois, founded over 40 years ago. The firm, known for its Leaders Strategy™, has a team including key figures like Collin Roche and Constantine Mihas, serving as Co-CEOs, backed by a diverse array of managing directors specialized in various domains. GTCR distinguishes itself through its collaborative approach, leveraging deep industry expertise to drive growth in its investments.

GTCR primarily invests in the financial services, technology, healthcare, and business and consumer services sectors, employing a strategy focused on buyouts and growth equities. While specific check sizes are not mentioned, the firm's focus on growth-stage companies implies investments typically range in the $50-100 million bracket. GTCR's presence is particularly strong in North America, with significant operations throughout this region.

Notable portfolio companies include Corza Medical - medical devices, Avelis Holdings - technology services, Fiduciary Trust Company - wealth management, and Zentiva - pharmaceuticals. The firm is known for its strategic acquisitions and successful exit strategies including sales to strategic investors and IPOs.

Industry

HealthTech Technology MedTech Telecommunications Software Pharmaceuticals Other Medical Devices Media and Entertainment Marketing and Advertising Healthcare Services Fintech Financial Services Edtech Education Consumer Services (B2C) Business Services (B2B) SaaS Security

GTCR Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
GTCR FUND XI/B LP
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$3900 M
January 2014
GTCR Fund XII
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$5300 M
October 2017
GTCR Fund XIII
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$7500 M
November 2020
GTCR Strategic Growth Fund
Private Equity (PE)
Financial Services
Healthcare Services
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$2000 M
January 2022
GTCR Strategic Growth Fund II
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$3600 M
February 2025
GTCR Fund XIV
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Marketing and Advertising
Media and Entertainment
SaaS
Security
Software
HealthTech
Series B
Late Stage (Series C+)
North America
$5-10 m
$11500 M
May 2023
Capital Solutions Fund
Private Equity (PE)
Business Services (B2B)
Consumer Services (B2C)
Financial Services
Healthcare Services
Media and Entertainment
Telecommunications
Technology
Late Stage (Series C+)
North America
$10-50 m
$1250 M
July 2026

Contacts

Name
Title
Email
avatar
Constantine S. Mihas Co-CEO and Managing Director
Co-CEO and Managing Director
c•••@•••
avatar
Collin E. Roche Co-CEO and Managing Director
Co-CEO and Managing Director
c•••@•••
Upgrade to see contacts
avatar
IF47knZegVujTBPJ IF47knZegVujTBPJ
IF47knZegVujTBPJ
avatar
IF47knZegVujTBPJ IF47knZegVujTBPJ
IF47knZegVujTBPJ
avatar
IF47knZegVujTBPJ IF47knZegVujTBPJ
IF47knZegVujTBPJ
Investment-team contacts for GTCR — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about GTCR

GTCR is a private equity firm. It backs companies at Series B, Series A and Late Stage (Series C+), writing tickets of $50-100 m.
GTCR is located in Chicago, Illinois, United States.
GTCR was founded in 1980.
GTCR invests in companies and startups in HealthTech, Technology, MedTech, Telecommunications, Software, Pharmaceuticals, Other, Medical Devices, Media and Entertainment, Marketing and Advertising, Healthcare Services, Fintech, Financial Services, Edtech, Education, Consumer Services (B2C), Business Services (B2B), SaaS, Security.
GTCR invests in companies and startups in North America, Europe.
GTCR invests in companies and startups at Series B, Series A, Late Stage (Series C+).
GTCR usually invests $50-100 m on average.
GTCR has around $40 000m assets under management.
GTCR last fund was created/launched in 2025-02-10
GTCR can be reached through its website gtcr.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for GTCR — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query GTCR directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.